Works matching IS 03331024 AND DT 2019 AND VI 39 AND IP 14
Results: 15
Corrigendum.
- Published in:
- 2019
- Publication type:
- corrected article
The biological clock in cluster headache: A review and hypothesis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Headache due to spontaneous spinal cerebrospinal fluid leak secondary to cerebrospinal fluid-venous fistula: Case series.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Risk factors and psychological impact of syncope in migraine patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Targeting CGRP via receptor antagonism and antibody neutralisation in two distinct rodent models of migraine-like pain.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Observational, open-label, non-randomized study on the efficacy of onabotulinumtoxinA in the treatment of nummular headache: The pre-numabot study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Basal astrocyte and microglia activation in the central nervous system of Familial Hemiplegic Migraine Type I mice.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Extracranial activation of ATP-sensitive potassium channels induces vasodilation without nociceptive effects.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Investigation of distinct molecular pathways in migraine induction using calcitonin gene-related peptide and sildenafil.
- Published in:
- 2019
- By:
- Publication type:
- journal article
CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Characterisation of vasodilatory responses in the presence of the CGRP receptor antibody erenumab in human isolated arteries.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cardio- and cerebrovascular safety of erenumab, a monoclonal antibody targeting CGRP receptors - important studies on human isolated arteries.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adults.
- Published in:
- 2019
- By:
- Publication type:
- journal article